The pharmaceutical sector in the national capital region, like many other industry sectors, seems to have turned the trend-setter for the rest of the country's pharma players with their global consolidation moves.
With the time nearing an end for the now enjoyed excise-free concessions and the recent correction in excise regime, the hitherto hot pharma destinations in Himachal Pradesh and Uttarakhand have started losing their sheen.
Though the cut in excise duty from 16 to 8 per cent has come as a relief to the small and medium pharma enterprises (SME) in the North India, especially the hilly states of Himachal Pradesh and Uttarakhand,
Omaxe Infrastructure and Construction Private Ltd (OICPL), a wholly owned subsidiary of Omaxe Ltd, would invest about Rs 250 crore to build an allopathic medical college and associated hospital at Saharanpur in Uttar Pradesh.
The Haryana-based Guardian Lifecare Private Limited, North India's largest pharmacy health and beauty chain store, is planning to enhance its foothold in the nutraceuticals market in India by increasing its number of stores to 400 by 2010.